DaVita Inc. announced its fourth quarter 2025 financial results, with consolidated revenues reaching $3.620 billion, an increase from the previous year. However, net income attributable to DaVita Inc. decreased to $234.217 million, down from $259.329 million in Q4 2024, and diluted EPS also saw a decline. The company highlighted strong platform delivery, high-quality care, and ongoing investments.
Consolidated revenues for Q4 2025 were $3.620 billion, showing growth from the prior year.
Net income attributable to DaVita Inc. for Q4 2025 was $234.217 million, a decrease compared to $259.329 million in Q4 2024.
Diluted earnings per share from continuing operations for Q4 2025 were $2.94, lower than $3.09 in Q4 2024.
The company repurchased 2.7 million shares for $331 million at an average price of $122.78 per share in Q4 2025.
DaVita's 2026 guidance projects adjusted operating income between $2.085 billion and $2.235 billion, adjusted diluted net income from continuing operations per share between $13.60 and $15.00, and free cash flow between $1.000 billion and $1.250 billion.
Analyze how earnings announcements historically affect stock price performance